These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6157303)

  • 1. Substances related to 5-hydroxytryptamine in plasma and in lumbar and ventricular fluids of psychiatric patients.
    Curzon G; Kantamaneni BD; Van Boxel P; Gillman PK; Bartlett JR; Bridges PK
    Acta Psychiatr Scand Suppl; 1980; 280():3-20. PubMed ID: 6157303
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain serotonin, affective illness, and antidepressant drugs: cerebrospinal fluid studies with probenecid.
    Goodwin FK; Post RM
    Adv Biochem Psychopharmacol; 1974; 11(0):341-55. PubMed ID: 4276863
    [No Abstract]   [Full Text] [Related]  

  • 3. Precursors and metabolites of 5-hydroxytryptamine and dopamine in the ventricular cerebrospinal fluid of psychiatric patients.
    Bridges PK; Bartlett JR; Sepping P; Kantamaneni BD; Curzon G
    Psychol Med; 1976 Aug; 6(3):399-405. PubMed ID: 996200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness.
    Ashcroft GW; Blackburn IM; Eccleston D; Glen AI; Hartley W; Kinloch NE; Lonergan M; Murray LG; Pullar IA
    Psychol Med; 1973 Aug; 3(3):319-25. PubMed ID: 4147078
    [No Abstract]   [Full Text] [Related]  

  • 5. Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites.
    Bowers MB; Heninger GR
    Commun Psychopharmacol; 1977; 1(2):135-45. PubMed ID: 603996
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebral transmitter precursors and metabolites in advanced renal disease.
    Sullivan PA; Murnaghan D; Callaghan N; Kantamaneni BD; Curzon G
    J Neurol Neurosurg Psychiatry; 1978 Jul; 41(7):581-8. PubMed ID: 29080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and serotonin metabolism in hepatic encephalopathy.
    Knell AJ; Davidson AR; Williams R; Kantamaneni BD; Curzon G
    Br Med J; 1974 Mar; 1(5907):549-51. PubMed ID: 4817189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmitter precursors and metabolites in human ventricular cerebrospinal fluid.
    Curzon G; Kantamaneni BD; Bartlett JR; Bridges PK
    J Neurochem; 1976 Mar; 26(3):613-5. PubMed ID: 4585
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-Hydroxytryptamine metabolism in affective illness: the effect of tryptophan administration.
    Ashcroft GW; Crawford TB; Cundall RL; Davidson DL; Dobson J; Dow RC; Eccleston D; Loose RW; Pullar IA
    Psychol Med; 1973 Aug; 3(3):326-32. PubMed ID: 4729192
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain transmitter precursors and metabolites in diabetic ketoacidosis.
    Curzon G; Kantamaneni BD; Callaghan N; Sullivan PA
    J Neurol Neurosurg Psychiatry; 1982 Jun; 45(6):489-93. PubMed ID: 6181209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
    Eklundh T; Eriksson M; Sjöberg S; Nordin C
    J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function relations in schizophrenia: brain morphology and neuropsychology.
    Bilder RM
    Prog Exp Pers Psychopathol Res; 1992; 15():183-251. PubMed ID: 1285281
    [No Abstract]   [Full Text] [Related]  

  • 13. [Urinary excretion of 5-hydroxyindoleacetic acid and serum tryptophan and serotonin levels in patients with depression].
    Pietruszewska I; Jasińska M; Lewicka-Wysocka H; Marcjan K; Stencka K
    Psychiatr Pol; 1984; 18(1):9-16. PubMed ID: 6204348
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-Hydroxyindoleacetic acid, homovanillic acid and tryptophan levels in CSF above and below a complete block of CSF flow.
    Young SN; Lal S; Martin JB; Ford RM; Sourkes TL
    Psychiatr Neurol Neurochir; 1973; 76(6):439-44. PubMed ID: 4781523
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebrospinal fluid amine metabolites in affective illness and schizophrenia: clinical and pharmacological studies.
    Goodwin FK; Post RM
    Psychopharmacol Commun; 1975; 1(6):641-53. PubMed ID: 1224017
    [No Abstract]   [Full Text] [Related]  

  • 16. Tryptophan and tyrosine catabolic pattern in neuropsychiatric disorders.
    Ravikumar A; Deepadevi KV; Arun P; Manojkumar V; Kurup PA
    Neurol India; 2000 Sep; 48(3):231-8. PubMed ID: 11025626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel variation of homovanillic acid, 5-hydroxyindoleacetic acid and cyclic adenosine-3, 5-monophosphate in ventricular cerebrospinal fluid of man.
    Inagawa T
    Hiroshima J Med Sci; 1982 Jun; 31(2):117-21. PubMed ID: 6182129
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of tryptophan metabolism via serotonin in cerebrospinal fluid of patients with noncommunicating hydrocephalus using a new endoscopic technique.
    Comai S; Longatti P; Perin A; Bertazzo A; Ragazzi E; Costa CV; Allegri G
    J Neurosci Res; 2006 Aug; 84(3):683-91. PubMed ID: 16721766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant treatments and alterations in central serotonin turnover in affective illness.
    Jimerson DC; Post RM; Goodwin FK
    Monogr Neural Sci; 1976; 3():15-22. PubMed ID: 790167
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of age, height, and body weight on cerebrospinal fluid amine metabolites and tryptophan in women.
    Banki CM; Molnar G
    Biol Psychiatry; 1981 Aug; 16(8):753-62. PubMed ID: 6169376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.